These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 25775069)
21. Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma. Hattangadi JA; Hong TS; Yeap BY; Mamon HJ Cancer; 2009 Aug; 115(16):3640-50. PubMed ID: 19514088 [TBL] [Abstract][Full Text] [Related]
22. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
23. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience. Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW Am J Clin Oncol; 2012 Apr; 35(2):136-40. PubMed ID: 21325937 [TBL] [Abstract][Full Text] [Related]
24. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). Corsini MM; Miller RC; Haddock MG; Donohue JH; Farnell MB; Nagorney DM; Jatoi A; McWilliams RR; Kim GP; Bhatia S; Iott MJ; Gunderson LL J Clin Oncol; 2008 Jul; 26(21):3511-6. PubMed ID: 18640932 [TBL] [Abstract][Full Text] [Related]
25. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T; Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067 [TBL] [Abstract][Full Text] [Related]
26. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Staley CA; Lee JE; Cleary KR; Abbruzzese JL; Fenoglio CJ; Rich TA; Evans DB Am J Surg; 1996 Jan; 171(1):118-24; discussion 124-5. PubMed ID: 8554125 [TBL] [Abstract][Full Text] [Related]
27. Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759]. Knaebel HP; Märten A; Schmidt J; Hoffmann K; Seiler C; Lindel K; Schmitz-Winnenthal H; Fritz S; Herrmann T; Goldschmidt H; Krempien R; Mansmann U; Debus J; Diehl V; Büchler MW BMC Cancer; 2005 Apr; 5():37. PubMed ID: 15826316 [TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant chemoradiation and pancreaticoduodenectomy for initially locally advanced head pancreatic adenocarcinoma. Turrini O; Viret F; Moureau-Zabotto L; Guiramand J; Moutardier V; Lelong B; Giovannini M; Delpero JR Eur J Surg Oncol; 2009 Dec; 35(12):1306-11. PubMed ID: 19576722 [TBL] [Abstract][Full Text] [Related]
29. Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study. Hsu CC; Herman JM; Corsini MM; Winter JM; Callister MD; Haddock MG; Cameron JL; Pawlik TM; Schulick RD; Wolfgang CL; Laheru DA; Farnell MB; Swartz MJ; Gunderson LL; Miller RC Ann Surg Oncol; 2010 Apr; 17(4):981-90. PubMed ID: 20087786 [TBL] [Abstract][Full Text] [Related]
31. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. Dikken JL; Jansen EP; Cats A; Bakker B; Hartgrink HH; Kranenbarg EM; Boot H; Putter H; Peeters KC; van de Velde CJ; Verheij M J Clin Oncol; 2010 May; 28(14):2430-6. PubMed ID: 20368551 [TBL] [Abstract][Full Text] [Related]
32. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. Herman JM; Swartz MJ; Hsu CC; Winter J; Pawlik TM; Sugar E; Robinson R; Laheru DA; Jaffee E; Hruban RH; Campbell KA; Wolfgang CL; Asrari F; Donehower R; Hidalgo M; Diaz LA; Yeo C; Cameron JL; Schulick RD; Abrams R J Clin Oncol; 2008 Jul; 26(21):3503-10. PubMed ID: 18640931 [TBL] [Abstract][Full Text] [Related]
33. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database. Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387 [TBL] [Abstract][Full Text] [Related]
34. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus. Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492 [TBL] [Abstract][Full Text] [Related]
35. Economic Analysis of Adjuvant Chemoradiotherapy Compared with Chemotherapy in Resected Pancreas Cancer. Vela N; Davis LE; Cheng SY; Hammad A; Liu Y; Kagedan DJ; Paszat L; Bubis LD; Earle CC; Myrehaug S; Mahar AL; Mittmann N; Coburn NG; Ann Surg Oncol; 2019 Dec; 26(13):4193-4203. PubMed ID: 31535303 [TBL] [Abstract][Full Text] [Related]
36. Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study. Ferrandina G; Gambacorta A; Gallotta V; Smaniotto D; Fagotti A; Tagliaferri L; Foti E; Fanfani F; Autorino R; Scambia G; Valentini V Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):778-85. PubMed ID: 25585781 [TBL] [Abstract][Full Text] [Related]
37. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer. Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M J BUON; 2013; 18(2):385-90. PubMed ID: 23818350 [TBL] [Abstract][Full Text] [Related]
38. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial. Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348 [TBL] [Abstract][Full Text] [Related]
39. Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas. Hristov B; Reddy S; Lin SH; Cameron JL; Pawlik TM; Hruban RH; Swartz MJ; Edil BH; Kemp C; Wolfgang CL; Herman JM Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):176-80. PubMed ID: 19394156 [TBL] [Abstract][Full Text] [Related]
40. Role of Adjuvant Chemoradiotherapy for Duodenal Cancer: An Updated Analysis of Long-Term Follow-Up from Single Institution. Jang BS; Park HJ; Kim K; Jang JY; Kim SW; Oh DY; Chie EK World J Surg; 2018 Oct; 42(10):3294-3301. PubMed ID: 29869181 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]